HAV implantation

BIOLOGICAL2 trials

Sponsors

Humacyte, Inc.

Conditions

Peripheral Arterial DiseasePeripheral Vascular DiseaseTraumaTrauma BluntTrauma InjuryTrauma, Multiple

Unknown Phase

Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD

CompletedNCT01872208

Humacyte, Inc.Peripheral Arterial Disease, Peripheral Vascular Disease

Start: 2013-10-10End: 2024-07-18Updated: 2024-11-13

An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma

CompletedNCT05873959

Humacyte, Inc.Trauma, Trauma Blunt, Trauma Injury +1

Start: 2023-05-01End: 2024-01-15Updated: 2024-11-25

Related Papers

Bioengineered Human Arteries for the Repair of Vascular Injuries.

2025-02-0118 citations

Biological mechanisms of infection resistance in tissue engineered blood vessels compared to synthetic expanded polytetrafluoroethylene grafts.

2023-07-147 citations